Skip to main content

Continuum Advisory, LLC

SEC CIK
0001846532
Latest filing
Aug 6, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Continuum Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
13,684
Value
$3.44M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Continuum Advisory, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,684$3.44M0.3%−167−1.2%ReducedHolders
Q1 202613,851$3.01M0.3%−64−0.5%ReducedHolders
Q4 202513,915$3.18M0.3%+144+1.0%AddedHolders
Q3 202513,771$3.19M0.3%−35−0.3%ReducedHolders
Q2 202513,806$2.56M0.3%−622−4.3%ReducedHolders
Q1 202514,428$3.02M0.4%+23+0.2%AddedHolders
Q4 202414,405$2.56M0.3%+96+0.7%AddedHolders
Q3 202414,309$2.43M0.3%+604+4.4%AddedHolders
Q2 202413,705$2.35M0.3%−32−0.2%ReducedHolders
Q1 202413,737$2.20M0.3%+5,107+59.2%AddedHolders
Q4 20238,630$1.34M0.2%−3,163−26.8%ReducedHolders
Q3 202311,793$1.76M0.3%−24−0.2%ReducedHolders
Q2 202311,817$1.59M0.3%−193−1.6%ReducedHolders
Q1 202312,010$1.91M0.3%+1,106+10.1%AddedHolders
Q4 202210,904$1.76M0.3%+132+1.2%AddedHolders
Q3 202210,772$1.45M0.3%+453+4.4%AddedHolders
Q2 202210,319$1.58M0.3%−123−1.2%ReducedHolders
Q1 202210,442$1.53M0.3%+751+7.7%AddedHolders
Q4 20219,691$1.31M0.3%+102+1.1%AddedHolders
Q3 20219,589$1.03M0.3%−611−6.0%ReducedHolders
Q2 202110,200$1.15M0.4%+473+4.9%AddedHolders
Q1 20219,727$1.04M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.